US DOE Selects Ocean Power Technologies To Support Development Of Wave Energy Converter Concept

Ocean Power Technologies Inc (NYSE:OPTT) has been selected by the U.S. Department of Energy (DOE) to further the development of a…

byAkanksha

August 17, 2021

1 minute read

Ocean Power Technologies Inc (NYSE:OPTT) has been selected by the U.S. Department of Energy (DOE) to further the development of a next-generation wave energy converter.
The company will receive up to $197,203 to perform a preliminary conceptual design and feasibility study of a modular and scalable small-scale Mass-on-Spring Wave Energy Converter (MOSWEC) PowerBuoy for powering autonomous ocean monitoring systems.
Ocean Power Technologies holds multiple patents related to MOSWEC technology, which generates power from the relative motion caused by the ocean waves.
Price Action: OPTT shares are trading higher by 3.74% at $1.94 during the premarket session on Tuesday.

Netflix And Chill Out With The Pricing Rumors: Streamer Denies $7 To $9 Ad-Supported Plan

By Chris Katje

Today, 5:23 AM

Streaming giant Netflix Inc (NASDAQ: NFLX) has remained secretive on pricing and details for its upcoming ad-supported plan. The company refuted recent claims of pricing estimates by Bloomberg.

DIS

RCI Hospitality Clocks 91.6% Sales Growth In Q4 For Nightclubs, Bombshells Restaurants

By Shivani Kumaresan

Today, 5:23 AM

RCI Hospitality Holdings Inc (NASDAQ:RICK) reported fourth-quarter FY21 total sales for Nightclubs and Bombshells restaurants of $54.4 million, representing…

RICK

Aerojet Rocketdyne Shareholder ‘Committee For Aerojet Rocketdyne Shareholders’ Sends Letter, Welcomes Co. Chair’s ‘About Face,’ Concession To Release Results On Internal Probe

By Benzinga Newsdesk

Today, 5:23 AM

Eileen Drake (the CEO of Aerojet Rocketdyne (NYSE: AJRD)) and Gen. Kevin Chilton (Ret.), Thomas Corcoran and Gen. Lance Lord (Ret.) (three of its Independent Directors) today issued the following statement:

AJRD

EXCLUSIVE: Pasithea Expands Its Footprint With Second Ketamine Therapy Clinic In UK

By Vandana Singh

Today, 5:23 AM

Pasithea Therapeutics Corp's (NASDAQ: KTTA) subsidiary, Pasithea Clinics, has opened its second London clinic in Marylebone, offering intravenous (IV) ketamine therapy to patients suffering from treatment-resistant mental health issues.

KTTA

US DOE Selects Ocean Power Technologies To Support Development Of Wave Energy Converter Concept

Related Posts

Netflix And Chill Out With The Pricing Rumors: Streamer Denies $7 To $9 Ad-Supported Plan

RCI Hospitality Clocks 91.6% Sales Growth In Q4 For Nightclubs, Bombshells Restaurants

Aerojet Rocketdyne Shareholder ‘Committee For Aerojet Rocketdyne Shareholders’ Sends Letter, Welcomes Co. Chair’s ‘About Face,’ Concession To Release Results On Internal Probe

EXCLUSIVE: Pasithea Expands Its Footprint With Second Ketamine Therapy Clinic In UK